Ocrevus infusion protocol

HSE Prescribing Protocol for Ocrelizumab (Ocrevus ) for RMS PPMS Protocol: HSE Prescribing Protocol Ocrelizumab (Ocrevus )for the Treatment of Relapsing Multiple Sclerosis (RMS) and Primary Progressing Multiple Sclerosis (PPMS) Published: May 2024 Review: May 2024 Version number: 1.0 Protocol Code: MS103a,b

As noted on the Ocrevus website, an Ocrevus infusion costs an estimated $65,000 annually – but the majority of patients will not pay this amount

OCREVUS can cause serious side effects, including: Infusion reactions: Infusion reactions are a common side effect of OCREVUS, which can be serious and may require you to be hospitalized. You will be monitored during your infusion and for at least 1 hour after each infusion of OCREVUS for signs and symptoms of an infusion reaction.

Infusion Protocols for Multiple Sclerosis Disease Modifying Therapies Alemtuzumab Infusion Protocol Cyclphosphamide Infusion Protocol IVIG Infusion Protocol.

Infusion supplies Infusion related reaction medications (ie, Benadryl, epi-pen, etc,) Other Filter (0.2 or 0.22 micron in-line) Please see the OCREVUS infusion-related reaction protocol in the OCREVUS Prescribing Information. PATIENT INFORMATION/INSURANCE PRESCRIBER INFORMATION DIAGNOSIS/PRESCRIPTION INFORMATION Additional information and

OCREVUS is an infusion that is given every 6 months. OCREVUS is an infusion therapyalso known as IV therapythat is given through an IV placed in your arm.

From Ocrevus to Tysabri: I time the first Tysabri infusion to be 6 months after the last Ocrevus infusion, when the patient would be due for their next

Infusion reactions: Infusion reactions are a common side effect of OCREVUS, which can be serious and may require you to be hospitalized. You will be monitored during your infusion and for at least 1 hour after each infusion of OCREVUS for signs and symptoms of an infusion reaction.

Checklist and steps to be completed by infusion nurse for Ocrelizumab (Ocrevus) Ocrelizumab protocol v. Supersedes: Ocrelizumab